JP2014520892A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014520892A5 JP2014520892A5 JP2014521786A JP2014521786A JP2014520892A5 JP 2014520892 A5 JP2014520892 A5 JP 2014520892A5 JP 2014521786 A JP2014521786 A JP 2014521786A JP 2014521786 A JP2014521786 A JP 2014521786A JP 2014520892 A5 JP2014520892 A5 JP 2014520892A5
- Authority
- JP
- Japan
- Prior art keywords
- botulinum
- composition according
- botulinum toxin
- type
- toxin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161509700P | 2011-07-20 | 2011-07-20 | |
| US61/509,700 | 2011-07-20 | ||
| PCT/US2012/047405 WO2013013042A1 (en) | 2011-07-20 | 2012-07-19 | Botulinum toxins for use in a method for treatment of adipose deposits |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014520892A JP2014520892A (ja) | 2014-08-25 |
| JP2014520892A5 true JP2014520892A5 (cg-RX-API-DMAC7.html) | 2016-06-16 |
Family
ID=46601917
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014521786A Pending JP2014520892A (ja) | 2011-07-20 | 2012-07-19 | 脂肪沈着物を処置するための方法におけるボツリヌス毒素の使用 |
Country Status (12)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9486408B2 (en) | 2005-12-01 | 2016-11-08 | University Of Massachusetts Lowell | Botulinum nanoemulsions |
| US9655926B1 (en) | 2013-08-23 | 2017-05-23 | Amiya Prasad | Treatment for hair thinning and hair loss |
| WO2016021985A1 (ko) * | 2014-08-07 | 2016-02-11 | 김상덕 | 보툴리눔 독소와 공기의 혼합물을 포함하는 안면 윤곽 교정용 조성물 및 이를 이용한 안면 윤곽 교정 방법 |
| US11111256B2 (en) | 2015-12-18 | 2021-09-07 | Jiangsu Nata Opto-Electronic Materials Co. Ltd. | High purity trisilylamine, methods of making, and use |
| AU2017360346B2 (en) | 2016-11-21 | 2023-11-23 | Eirion Therapeutics, Inc. | Transdermal delivery of large agents |
| RU2019141383A (ru) * | 2017-05-18 | 2021-06-18 | Реванс Терапьютикс, Инк. (Revance Therapeutics, Inc.) | Способы лечения цервикальной дистонии |
| US20190030118A1 (en) * | 2017-07-27 | 2019-01-31 | Ipsen Biopharm Limited | Treatment of lower limb spasticity |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9120306D0 (en) | 1991-09-24 | 1991-11-06 | Graham Herbert K | Method and compositions for the treatment of cerebral palsy |
| US5437291A (en) | 1993-08-26 | 1995-08-01 | Univ Johns Hopkins | Method for treating gastrointestinal muscle disorders and other smooth muscle dysfunction |
| US6974578B1 (en) | 1993-12-28 | 2005-12-13 | Allergan, Inc. | Method for treating secretions and glands using botulinum toxin |
| US5766605A (en) | 1994-04-15 | 1998-06-16 | Mount Sinai School Of Medicine Of The City University Of New York | Treatment of autonomic nerve dysfunction with botulinum toxin |
| US5670484A (en) | 1994-05-09 | 1997-09-23 | Binder; William J. | Method for treatment of skin lesions associated with cutaneous cell-proliferative disorders |
| ATE215832T1 (de) | 1994-05-09 | 2002-04-15 | William J Binder | Botulinumtoxin zur reduktion von migraine - kopfschmerzen |
| GB9508204D0 (en) | 1995-04-21 | 1995-06-07 | Speywood Lab Ltd | A novel agent able to modify peripheral afferent function |
| CA2505930C (en) | 1997-07-15 | 2008-01-29 | Richard A. Schmidt | Use of botulinum toxin in the preparation of a pharmaceutical composition for treating urinary retention |
| US6063768A (en) | 1997-09-04 | 2000-05-16 | First; Eric R. | Application of botulinum toxin to the management of neurogenic inflammatory disorders |
| US6113915A (en) | 1999-10-12 | 2000-09-05 | Allergan Sales, Inc. | Methods for treating pain |
| US6265379B1 (en) | 1999-10-13 | 2001-07-24 | Allergan Sales, Inc. | Method for treating otic disorders |
| US6139845A (en) | 1999-12-07 | 2000-10-31 | Allergan Sales, Inc. | Method for treating cancer with a neurotoxin |
| US6143306A (en) | 2000-01-11 | 2000-11-07 | Allergan Sales, Inc. | Methods for treating pancreatic disorders |
| US6358513B1 (en) | 2000-02-15 | 2002-03-19 | Allergan Sales, Inc. | Method for treating Hashimoto's thyroiditis |
| US6649161B1 (en) * | 2000-02-22 | 2003-11-18 | Allergan, Inc. | Method for treating hypocalcemia |
| US6464986B1 (en) | 2000-04-14 | 2002-10-15 | Allegan Sales, Inc. | Method for treating pain by peripheral administration of a neurotoxin |
| US6299893B1 (en) | 2000-04-17 | 2001-10-09 | Marvin Schwartz | Method to reduce hair loss and stimulate hair regrowth |
| US6306423B1 (en) | 2000-06-02 | 2001-10-23 | Allergan Sales, Inc. | Neurotoxin implant |
| US6306403B1 (en) | 2000-06-14 | 2001-10-23 | Allergan Sales, Inc. | Method for treating parkinson's disease with a botulinum toxin |
| US6423319B1 (en) | 2000-10-04 | 2002-07-23 | Allergan Sales, Inc. | Methods for treating muscle injuries |
| EP1545207B1 (en) * | 2002-08-19 | 2018-03-14 | Ira Sanders | Treatment of holocrine gland dysfunction with clostridia neurotoxins |
| US8404249B2 (en) * | 2004-03-03 | 2013-03-26 | Revance Therapeutics, Inc. | Compositions and methods for topical application and transdermal delivery of botulinum toxins |
| US7179474B2 (en) * | 2004-09-03 | 2007-02-20 | Allergan, Inc. | Methods for treating a buttock deformity |
| CA2518650A1 (en) * | 2004-09-10 | 2006-03-10 | Dimitrios Dimitrakoudis | Clostridium botulinum toxin formulation and method for reducing weight |
| US20080220021A1 (en) * | 2005-02-14 | 2008-09-11 | Pankaj Modi | Topical Botulinum Toxin Compositions for the Treatment of Hyperhidrosis |
| US7727537B2 (en) * | 2005-02-14 | 2010-06-01 | Dpm Therapeutics Corp. | Stabilized compositions for topical administration and methods of making same |
| CN103919690B (zh) * | 2005-12-01 | 2020-07-31 | 麻萨诸塞州洛厄尔大学 | 肉毒杆菌纳米乳液 |
| WO2009026949A1 (en) * | 2007-08-31 | 2009-03-05 | Dsm Ip Assets B.V. | 4-amidino benzylamines for cosmetic and/or dermatological use |
| US20090297632A1 (en) * | 2008-06-02 | 2009-12-03 | Waugh Jacob M | Device, Methods and Compositions to Alter Light Interplay with Skin |
| CA2726836C (en) * | 2008-06-26 | 2019-06-18 | Anterios, Inc. | Use of nanoemulsions in the manufacture of a medicament for treating skin disorders |
| WO2010099587A1 (en) * | 2009-03-02 | 2010-09-10 | Doris Hexsel | Medicinal cosmetic lipoatrophy |
-
2012
- 2012-07-19 BR BR112014001066A patent/BR112014001066A2/pt not_active Application Discontinuation
- 2012-07-19 IN IN254DEN2014 patent/IN2014DN00254A/en unknown
- 2012-07-19 RU RU2014103543/15A patent/RU2014103543A/ru not_active Application Discontinuation
- 2012-07-19 EP EP12741438.1A patent/EP2734224A1/en not_active Withdrawn
- 2012-07-19 CN CN201280035860.8A patent/CN103702681A/zh active Pending
- 2012-07-19 CA CA2841955A patent/CA2841955A1/en not_active Abandoned
- 2012-07-19 WO PCT/US2012/047405 patent/WO2013013042A1/en not_active Ceased
- 2012-07-19 MX MX2014000612A patent/MX2014000612A/es unknown
- 2012-07-19 US US14/233,667 patent/US20140127188A1/en not_active Abandoned
- 2012-07-19 AU AU2012283968A patent/AU2012283968B2/en not_active Ceased
- 2012-07-19 JP JP2014521786A patent/JP2014520892A/ja active Pending
- 2012-07-19 KR KR1020147004213A patent/KR20140082956A/ko not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014520892A5 (cg-RX-API-DMAC7.html) | ||
| JP2014505733A5 (cg-RX-API-DMAC7.html) | ||
| PH12017501079A1 (en) | 1,3-thiazol-2-yl substituted benzamides | |
| JP2010222367A5 (cg-RX-API-DMAC7.html) | ||
| WO2014205389A8 (en) | Nuclear transport modulators and uses thereof | |
| IN2014MN02288A (cg-RX-API-DMAC7.html) | ||
| IN2014DN09434A (cg-RX-API-DMAC7.html) | ||
| BR112014032699A2 (pt) | métodos de tratamento de síndrome metabólica pediátrica | |
| CL2014002757A1 (es) | Compuestos derivados de benzamida para inhibir la actividad de abl1, abl2 y bcr-abl1, composicion farmaceutica; y uso en el tratamiento del cancer. | |
| MX340985B (es) | Compuestos de n-heteroarilo. | |
| EA201391119A1 (ru) | Системы доставки наночастиц, их получение и применение | |
| PH12017500706B1 (en) | Composition containing extract or fraction of genus justicia plant | |
| WO2015195684A3 (en) | Small molecule anti-scarring agents | |
| WO2016191458A3 (en) | Pharmaceutical compositions affecting mitochondrial redox state and methods of treatment | |
| WO2016030899A8 (en) | Methods of treating amyotrophic lateral scleroses | |
| MX384947B (es) | Composiciones en suspension de ciclosporina a para inyecciones subconjuntivales y perioculares. | |
| EA201491532A1 (ru) | Фармацевтические композиции для использования в комплексной терапии | |
| MX367926B (es) | Composicion farmaceutica para liberacion sostenida de lanreotida. | |
| BR112016007238A2 (pt) | tienouracilcarboxamidas cíclicas e sua utilização | |
| MX2014014579A (es) | Composiciones farmaceuticas topicas de tipo emulsion aceite en agua que contienen un retinoide. | |
| BR112015027992A2 (pt) | uso de ácido petroselínico para combater desordens estéticas da figura do corpo | |
| JP2015508052A5 (cg-RX-API-DMAC7.html) | ||
| WO2015004634A3 (es) | Combinación sinergística de paracetamol/celecoxib para el tratamiento de dolor inflamatorio | |
| EA201690574A1 (ru) | Применение пидотимода в лечении заболеваний, связанных с воспалением | |
| UA109944U (uk) | Фармацевтична композиція для зниження рівня n-оксиду триметиламіну |